Barron's Logo

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.

https://www.barrons.com/articles/rsv-vaccine-approval-pfizer-6ac6a7cb

The First Vaccines for RSV Are Coming Soon. What to Know.

By
Josh Nathan-Kazis
  • Order Reprints
  • Print Article

Moderna has said it plans to apply for FDA approval of its older adult RSV vaccine before the end of June.

Joe Raedle/Getty Images

Late last year, when a surge of respiratory syncytial virus infections hospitalized roughly 500 out of every 100,000 U.S. children under the age of 4, there was little to be done to blunt the disease’s impact.

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.